PSIL 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

PSIL

AdvisorShares Psychedelics ETF

收盤價 11月11日 9:46 AM ET（韓國 11/11 23:46）

$19.98

-0.25 ▼ -1.24%

對稱三角形阻力線 21.36 支撐線 18.70 維持連續2天同一條線

AI 繪製的圖表形態僅供參考。

詳細指標表

Category ⓘ	Global or ExUS Equities - Industry Sector	Expense ⓘ	1%	Return% 1Y ⓘ	24.26%	Total Holdings ⓘ	29	Perf Week ⓘ	2.41%	Volume ⓘ	21,884
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$44M	Return% 3Y ⓘ	16.38%	NAV ⓘ	$20.25	Perf Month ⓘ	-5.98%	Avg Volume ⓘ	0.03M
ETF Type ⓘ	Global Equities	Dividend TTM ⓘ	$1.68 (8.43%)	Return% 5Y ⓘ	-24.55%	52W High ⓘ	-26.05%	Perf Quarter ⓘ	-21.43%	Rel Volume ⓘ	0.69
Active/Passive ⓘ	Active	Div Gr. 3/5Y ⓘ	51.35% -	Return% 10Y ⓘ	-	52W Low ⓘ	27.79%	Perf Half Y ⓘ	0.25%	Prev Close ⓘ	$20.23
IPO ⓘ	2021/9/16	Flows% 1M ⓘ	0%	Return% SI ⓘ	-24.47%	RSI (14) ⓘ	43.98	Perf YTD ⓘ	16.37%	Price ⓘ	$19.98
Beta ⓘ	0.99	Flows% 3M ⓘ	6.11%	Flows% YTD ⓘ	120.27%	Flows% 1Y ⓘ	133.77%	Perf Year ⓘ	9.65%	Volatility(W/M) ⓘ	4.21% 3.63%
SMA20 ⓘ	-1.72%	SMA50 ⓘ	-10.02%	SMA200 ⓘ	-3.97%	ATR ⓘ	0.77

ETF 簡介

AdvisorShares Psychedelics ETFPSIL | NYSE | 股息收益型查看深度分析

AdvisorShares Psychedelics ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

PSIL ETF 一覽

1% 越低越好

$44M 管理資產

29檔

8.43%

掛牌日 2021年

管理方式主動管理

發行公司 AdvisorShares

主要持有標的持有 29 檔

前 10 大持股占 基金的 69%

集中在少數幾檔。它們波動時，ETF 也會跟著波動。